10x Genomics, Inc. (TXG)
NASDAQ: TXG · Real-Time Price · USD
24.83
+1.25 (5.30%)
Apr 14, 2026, 3:50 PM EDT - Market open
10x Genomics Market Cap
10x Genomics has a market cap or net worth of $3.17 billion as of April 14, 2026. Its market cap has increased by 175.63% in one year.
Market Cap
3.17B
Enterprise Value
2.77B
1-Year Change
175.63%
Ranking
Category
Stock Price
$24.83
Market Cap Chart
Since September 12, 2019, 10x Genomics's market cap has decreased from $4.95B to $3.17B, a decrease of -35.92%. That is a compound annual growth rate of -6.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 13, 2026 | 3.01B | 45.94% |
| Dec 31, 2025 | 2.06B | 18.74% |
| Dec 31, 2024 | 1.74B | -73.72% |
| Dec 29, 2023 | 6.61B | 58.59% |
| Dec 30, 2022 | 4.17B | -74.93% |
| Dec 31, 2021 | 16.64B | 9.21% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 12, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BrightSpring Health Services | 9.39B |
| Tempus AI | 8.25B |
| HealthEquity | 6.75B |
| Waystar Holding | 4.25B |
| Doximity | 4.19B |
| Hinge Health | 2.98B |
| Privia Health Group | 2.89B |
| HeartFlow | 2.35B |